Firering Strategic Minerals: From explorer to producer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Started: stuartlwright, 30 Apr 2024 10:26
Last post: brazos, 29 May 2024 19:18
42.5m shares of 1p each after consolidation.
You can lookup the latest filing on companies house for Arcturis data from what I can see the value of each share is 80 p after the consolidation
Yes, same here... but don't know what/how many there are in circulation or value...
Hi All - hope all ok - can anyone tell the latest update here - It looks as though I have been switched to 1 share for every 100 thatI had but still no value to them - are we expecting news? TIA
Started: JPWrighty, 18 Apr 2024 10:20
Last post: JPWrighty, 19 Apr 2024 08:46
Thank you, and fingers very much crossed for us all on this one!
Furion, I'm in for about the same.
Good luck, everybody, let's hope our patience is rewarded.
On potentially raising funds, let's remember that they got some backing from institutional investors after going private, thanks to Alex Snow, so they do have some decent runway still, and doubt these investors are in for a 5-10% return.
100:1 so for every 100 you get 1 so 300,000 divided by 100 is 3000
Hope that’s right
GLA
I have been told that the 300,000 approximate share will be transformed into 300 in... Acturis Data? Seem correct?
Started: LuckyBear12, 22 Dec 2023 16:31
Last post: micru, 17 Apr 2024 07:25
>So it looks like they may relist. But when? And as has been said on this board, they'll probably fund raise.
I remember writing something like 'see you all in 2025' when it de-listed, looks like could be right. I think if we all survive to the end of this year, US elections could drive market sentiment quite a lot, and it will be more favourable to activity again.
So it looks like they may relist. But when? And as has been said on this board, they'll probably fund raise.
Thank you
So it’s probably same then
3000 at £1.83 is what mine is showing
Cheers
Mine still shows as Sensyne and shows the number of consolidated shares and consolidated value.
Does it show as Arcturis on your account and the number of shares ?
Mine still shows as sensyne health 3000 shares
Could it be because I didn’t vote ? Surly not
Thank you
Started: ripley94, 19 Apr 2022 15:52
Last post: ripley94, 16 Apr 2024 09:38
Thankyou brazos.
For this information mine held with broker , no information.
RE: Arcturis Data limited6 Apr 2024 19:36
100:1 consolidation. So they are proposing a consolidation and a sub-division. I received a copy of the document and you are spot on micru. I quote ''The purpose of the sub-division is to reduce the nominal value of the Consolidated Ordinary shares to a level which provides flexibility for future issues of ordinary shares''
I hope we will be invited to participate should there be any future issuing of equity, otherwise we will be diluted to oblivion. Those who own less that 100 shares will cease to be shareholders following this proposed exercise.
In any case, I hope LTHs will be able to come out with something in the end.
Stock Split Adjustment on account today.
Costly gamble .
Looks like it will be complete loss eventually no listing , old share holders interest will not be looked after .
Might of been a little mad .
Looks like others posted buys at same time.
>Not sure what made me top up on 25th May 2022
Eternal optimism, haha! The optimism is still valid.
Not sure what made me top up on 25th May 2022
Tue, 19th Apr 2022 (Alliance News)
Sensyne Health shares plummet as AIM delisting proposed
Sensyne Health PLC shares slump on Tuesday as the company proposed delisting from London's AIM junior market.
The company is seeking approval from its shareholders for the delisting of the shares, in accordance with AIM rules, Sensyne Health explained.
It will hold a general meeting on May 20.
Sensyne Health shares were 32% lower at 1.24 pence each in London on Tuesday morning.
The firm, led by Alex Snow as its new chief executive officer since Monday, amended and restated a note purchase agreement to provide for the issue of up to GBP20 million of loan notes. This brings the total number of loan notes to GBP26.4 million.
The company said the loan notes are purchased - or will be purchased - in tranches.
One tranche of a principal amount of GBP6.4 million was issued to original purchasers on January 28.
Another tranche of GBP6.0 million will be issued to Gatemore Investment Partners I LP, Lansdowne and MNL (Hambro Perks) Nominees Limited on or around April 21.
Two subsequent tranches of loan notes will be issued at the request of the company, with new Sensyne Health Chief Executive Alex Snow, who is the former CEO of Lansdowne Partners UK LLP, allowed to subscribe for up to GBP2.0 million of additional notes.
The company had been under a formal sales process since November.
"In light of the amended financing terms, the board has decided to end the formal sale process with immediate effect," Sensyne said.
The Oxford, England-based clinical artificial intelligence company is also seeking the approval of shareholders to re-designate ordinary shares of 10 pence. Under the plan, those shares will be sub-divided and re-designated into one ordinary share of GBP0.008 in the capital of the company and GBP0.092 as a deferred share in the capital of the company.
Isn't the news going to be it will delist? Is there a realistic chance that this will not happen?
Started: init2oneit, 15 Nov 2023 16:03
Last post: init2oneit, 15 Nov 2023 16:03
Started: SteadyAIMfire, 2 Nov 2023 16:57
Last post: init2oneit, 13 Nov 2023 18:35
Started: SteadyAIMfire, 25 Sep 2023 18:12
Last post: SteadyAIMfire, 25 Sep 2023 18:12
We're proud to have 6 poster presentations accepted at this year's #ISPOREurope conference in Copenhagen. We are also delighted to announce that Shammi Luhar has been invited to give a podium presentation. Follow us to find out more in the coming weeks or visit https://lnkd.in/ec6AKWc5.
Started: init2oneit, 21 Jun 2023 15:52
Last post: init2oneit, 23 Sep 2023 16:41
Companies House now show accounts Apr thru to Dec 22 now due end of December.
Accounts year has changed to Jan to Dec with April to Dec 22 being a shortened year for accounts as per document filed at Companies House.
Accounts and accompanying statements now available to view at Companies House website.
At long last the Co has lodged the accounts year ending April 22, when they were a listed Co with Companies House and according to the message on that site, they should be available within 10 days. Laura Hillier has also stood down as Company Secretary, that was in a separate notification published last week.
Started: SteadyAIMfire, 24 Aug 2023 07:35
Last post: init2oneit, 2 Sep 2023 10:07
They seem to have assembled quite a team as per details to be seen on the website. Recruitment continues with platform engineers etc, all details via website or their LinkedIn page. They have a shortened financial year for 22 from April until December. According to Companies House those accounts are due for publication end of this month. There should be some kind of statement within the results on the development and progress of the business. Whether they can say too much at this stage remains to bed seen.
Has anyone had any joy reaching out to the company for any progress updates?
Started: init2oneit, 28 Jun 2023 13:03
Last post: init2oneit, 29 Jun 2023 09:44
A lot of tiding up of the corporate side of the Company. Release finally of year end accounts April 22. Changed subsequent financial years to Jan to Dec with shortened period last year to April until December. Change of Co secretary and release of major holders with the annual statement. With the Times article it is suggested they are near to closing major pharma deals to take advantage of their unique IP. Hopefully we may see some news of this quite soon
The document provides details of holdings above 5 per cent and amongst others Alex Snow has invested and holds 250 m that’s 2m quid at the 008 pence per share.
Started: init2oneit, 23 Jun 2023 16:19
Last post: init2oneit, 23 Jun 2023 16:19
Kate Bingham: we have a golden opportunity to give the NHS a hand
to take advantage of its partnerships with the NHS trusts and as per statement with accounts releases the Co plan to concentrate on UK operations.
https://www.thetimes.co.uk/article/ed2b06b4-1103-11ee-a92d-cf7c831c99b5?shareToken=ef03994d56ddd1a56d67dbaef211e09c
Started: daniscp1906, 6 Jun 2023 08:52
Last post: kn0wles, 16 Jun 2023 21:51
Click on the "historical data" tab
You never know, I bought 216269 shares at a cost of £1282.68 near the day of suspension so my average is 0.59p, it was always a very long term put for me as its in my LISA, still another 18 years till I can cash it in so in I'm in no hurry, lol, fingers crossed.
Not sure what the relevance of this is but I did notice yahoo finance has the daily share price of Arcturis, not much happening but the price changed from 0.0035 to 0.0051 on the 22nd of Feb?
https://finance.yahoo.com/quote/SSYNF/
At my average of 1.78 p, I’m certainly hopeful of a good return one day.
I'm not holding my breath that we will ever see any value here even if at some point Arcturis was to relist on the LSE, the below is taken from the Times article so anyone holding at suspension will have been diluted to oblivion as part of the refinancing deal.
"As part of the crucial refinancing, Arcturis secured about £24 million through three tranches of convertible shareholder loans, but this largely wiped out existing shareholders, including the NHS trusts and Drayson and his wife."
Enjoyed reading the article. Reassures me that the company will do well over time. (Another 2 /3 years). Alex snow is looking to build and sell when the time is right. A nice earner for everyone!
Started: init2oneit, 17 Oct 2022 13:17
Last post: micru, 6 Jun 2023 18:34
>Any news when company will relist
Current environment not very conducive to securing finance/doing listings or other such high-impact financial transactions.
Need to wait for the war to end/US presidential race outcome as a catalyst at a minimum. My personal view is towards 2025.
Not as far as I know. Looks like Alex is focusing on rebuilding the company at the moment. The last communication I received from the company said the total amount of shares in issue now stands at just over 4bn. Let’s hope the new outfit will be worth at leat £4bn when we go for IPO, that’s if they decide to do so.
Any news when company will relist and we will
Get our shares transferred?
But then again … maybe no coincidence at all.
Probably no more than coincidence with Arctoris.
https://www.barchart.com/story/news/10544722/arctoris-welcomes-on-board-globally-recognized-experts-in-machine-learning-chemical-computation-and-alzheimers-disease
Started: init2oneit, 29 Mar 2023 10:29
Last post: init2oneit, 19 May 2023 18:56
Sorry that didn’t copy and psste
Started: init2oneit, 15 May 2023 16:32
Last post: init2oneit, 15 May 2023 16:37
Expansion seems rapid
https://uk.linkedin.com/company/arcturis-data
Started: init2oneit, 24 Apr 2023 19:27
Last post: init2oneit, 28 Apr 2023 15:23
Thanks
…. and what’s great is Arcturis are promoting the article on their LinkedIn feed / latest update.
Great find init,
"Alex Snow, the former chairman of Exscientia, an AI drug discovery company, has been leading a restructuring of Arcturis to focus on its core patient data business and its partnerships with the NHS. He agrees that NHS data is the “gold standard” in healthcare data, but says that “accessing this anonymised data from multiple sources . . . is not always straightforward”.
Nice one initotwinit . Alex Snow if you read this....dont sell below a quid lol
I guess no one could be bothered to scroll down to the bottom of the article which I post again. It’s a great mention of Arcturis and the first words in public that I’ve seen from Alex Snow.
Article
https://www.thetimes.co.uk/article/d8250bf6-e292-11ed-9d9d-927ca944996b?shareToken=69f9d7d48006a726ae73f772aeccb656
They must be monitoring my posts. They’ve just put the same up on their latest LinkedIn update and confirms partnership with 13 NHS trusts
Started: SteadyAIMfire, 26 Apr 2023 23:27
Last post: init2oneit, 27 Apr 2023 22:43
See my latest update on NHS thread. They’ve just updated LinkedIn again with the same info I posted yesterday and confirm partnership with 13 NHS trusts.
A bit late there see my thread 13th October.
This paper has been out in the public domain fir sometime now
Recently posted research on LinkedIn -
We are delighted to share our joint paper with Bayer | Pharmaceuticals, published in the Journal of Medical Artificial Intelligence.
This study investigates approaches to perform patient stratification analysis at scale using large EHR datasets and multiple clustering methods for clinical research. We show examples on the effectiveness of the methods and hope to encourage further research in this field.
Read the paper at: https://lnkd.in/exrhHtsu
Bayer Pharmaceuticals - a company with a 60 billion euro market cap !
Last post: Umair020608, 1 Apr 2023 12:16
I received also but new to this can someone shed some light what it means much appreciated.
Just received a your vote counts email anyone else receive that looks promising!
GLA
Started: Jackbenimble94, 18 Mar 2023 21:45
Last post: Furion, 30 Mar 2023 13:16
Myn on II still shows as sensyne with a big -£5k in red :(
GLA
Does anybody else deal through AJ Bell, I have heard nothing from them but the company name has only just recently changed to "ARCTURIS DATA LTD ORD GBP0.10" in my account, thanks for the updates everyone it is much appreciated.
Your last para. Completely agree. With a legal ax COO a with these qualifications
https://solicitors.lawsociety.org.uk/person/99975/laura-hillier
Provides the right track in corporate governance. Hopefully we have some really good news on the horizon.
Just posting to say that I appreciate you all digging for updates and keeping the faith.
By the look of things the company has some good product and ideas, as well as really talented folks working in the background. Mr. Snow looks to be a serious operator, and to secure funding in such a challenging environment is impressive. Laura's response and willingness to put herself out there and be accountable says something as well. Could have easily stayed quiet.
They just needed to shake off some leeches and scnmbags and now need some time to recover.
Sounds promising. Should have contact with H&L soon or will send details through directly.
I have to eat humble pie. FFSBS did post Laura Hillier was now the COO but I could see nothing to verify that from the Co. No update at Companies House.
It’s all eyes glued then for the website to go fully live. Thanks again for your input
Started: Optimist187, 22 Mar 2023 17:19
Last post: Optimist187, 22 Mar 2023 17:19
What are the options for shares held by someone who only trades on LSE?
Started: init2oneit, 17 Mar 2023 11:17
Last post: init2oneit, 18 Mar 2023 19:38
Good spot.
More info
https://www.eucope.org/events/world-evidence-pricing-and-access-epa-congress/
Just put out there first post on LinkedIn too
Arcturis Data
Arcturis DataFollowing
165 followers
2h
Arcturis will be attending this year's World EPA Congress. If you are interested in chatting about how we collaborate with research and industry experts to create research-ready, regulatory grade disease-specific datasets, and produce powerful insights to support all phases of clinical development, get in touch with Abigail Lishman, Nick Scott-Ram, Alex Snow, Lewis Carpenter, Robert Dürichen
#realworldevidence #realworlddata #arcturisdata
1
Scroll down to info just below Roche.
Maybe just updated to show new name Arcturis but good to see NHS continue with Arcturis Data
https://www.goshdrive.com/partners
Started: daniscp1906, 3 Mar 2023 11:21
Last post: init2oneit, 13 Mar 2023 17:24
I guess you choose your handle wisely !
I would check your info about Hillier’s job title if I were you. Companies House website. No amount of emailing will get you info if it’s still confidential especially if you are trying to contact a job title thst does not exist anymore…. all of course if you can prove different
If you want to know what’s going on and why shareholders not communicated with them we should all email Laura, new COO. The more people who
Email her the better. I’ve been trying to get a status on where I stand. Awful
No comms from the company. Shd be a corporate action soon?
Kind regards
Laura
Laura Hillier
Chief Operating Officer (COO)
M: 07739 644 307
E:
laura.hillier@arcturisdata.com
the new name in real-world data
I haven’t posted lately. Still watching Companies House website where still no accounts have been published for year ending April 22. There seems to be a complete news blackout currently. Much to speculate on, there is still absolutely no news anywhere about their divestment even from the Co that bought the tech. Interestingly the 10 year lease on new office accommodation ties in with Moderna’s 10 year deal with the NHS and Government. With all of Arcturis’s connections and agreements with the NHS, a synergy could be developing here. Or maybe not, I guess we just have to be patient. It’s almost a year now since Snow was appointed.
https://www.gov.uk/government/news/uk-cements-10-year-partnership-with-moderna-in-major-boost-for-vaccines-and-research
Been a while looking in did this get reposted or moved or are we still just holding ? Still shows as zero value in my II and 300k holding shares
Cheers
Started: init2oneit, 10 Feb 2023 16:18
Last post: SteadyAIMfire, 25 Feb 2023 17:59
Quite a few openings now being advertised on LinkedIn - ‘a number of exciting projects’ sounds positive :)
Lewis Carpenter 3rd+
Head of Real-World Evidence at Arcturis
1w Edited
Follow
I am growing the Real-World Evidence team here at Arcturis!
We are involved in a number of exciting projects using our access to NHS real-world data and we're looking for medical statisticians with strong experience in research methods and statistics related to real-world evidence generation.
Proficiency in R required.
Please do get in touch if you are interested!
Arcturis Data
Can such potential be unlocked at Arcturis.
AI pioneer is laughing all the way back to the bank
https://www.thetimes.co.uk/article/5cf81ff0-a8a8-11ed-9c9e-78cbfe4237a1?shareToken=1d9ce9ad451e72f6b004e762a801f2f6
Started: brazos, 5 Feb 2023 13:42
Last post: brazos, 5 Feb 2023 13:52
“ Silicon Valley billionaires are lining up to bid for a £480m NHS contract to transform the health service’s creaking IT systems into a high tech database.
The so-called NHS Federated Data Platform has attracted a bid from US artificial intelligence company C3.AI, founded by billionaire Thomas Siebel, The Telegraph can reveal”
I remember Sensyne used to provide limited funding to upgrade Trusts’ IT systems. Maybe they could get involved in this massive project. As this isn’t their core business, mayb do it in partnership with another company…. Whoever gets it will be able to extract more than what they bargained for.